Compounds > ginkgolide b
Page last updated: 2024-08-24

ginkgolide b and rifampin

ginkgolide b has been researched along with rifampin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, HB; Collins, X; Edeki, TI; He, N; Strom, SC; Xie, HG1
Lombardo, F; Obach, RS; Waters, NJ1
Coy, ED; Cuca, LE; Sefkow, M1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

5 other study(ies) available for ginkgolide b and rifampin

ArticleYear
Induction of cyp3a in primary cultures of human hepatocytes by ginkgolides a and B.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:7

    Topics: Adult; Aged; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme Induction; Female; Ginkgolides; Hepatocytes; Herb-Drug Interactions; Humans; Hydroxylation; Lactones; Male; Middle Aged; Phenobarbital; Quercetin; Rifampin; Testosterone

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Macrophyllin-type bicyclo[3.2.1]octanoid neolignans from the leaves of Pleurothyrium cinereum.
    Journal of natural products, 2009, Volume: 72, Issue:7

    Topics: Animals; Antitubercular Agents; Bridged Bicyclo Compounds, Heterocyclic; Colombia; Lauraceae; Lignans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Leaves; Plants, Medicinal; Platelet Activating Factor; Rabbits; Stereoisomerism

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012